PlainRecalls
FDA Drug Moderate Class II Completed

Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,

Reported: January 11, 2023 Initiated: December 29, 2022 #D-0097-2023

Product Description

Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,

Reason for Recall

Lack of assurance of sterility: Bags have the potential to leak.

Details

Recalling Firm
Pfizer Inc.
Units Affected
62,088 bags
Distribution
Nationwide in the USA.
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,. Recalled by Pfizer Inc.. Units affected: 62,088 bags.
Why was this product recalled?
Lack of assurance of sterility: Bags have the potential to leak.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 11, 2023. Severity: Moderate. Recall number: D-0097-2023.